Call for Late-Breaking Abstracts for ObesityWeek® 2026
The Call for Late-Breaking Abstracts for ObesityWeek® 2026 is now closed.
Decision notifications were emailed to submitting authors from [email protected] September 8-14, 2026. Presentation assignments and scheduled presentation times have also been communicated to accepted presenters.
Accepted Abstract Presenters:
If your Late-Breaking Abstract was accepted, please:
- Confirm your participation using the link provided in the acceptance email
- Complete the required forms via the link provided within the acceptance email
- Review the Speaker Resource Center for presentation instructions, deadlines and meeting information
- Refer to your acceptance email for your assigned presentation format, date, and time
ObesityWeek® 2026
LATE-BREAKING ABSTRACTS
Submission Period Closed
Decision notifications and presentation schedules have been distributed to authors. Questions? Contact [email protected]
Judging Criteria
Reviewers will be assessing the quality of abstracts based on the following criteria:
Significance
- How meaningful and novel the data are to obesity research and treatment
- Whether the purpose or hypothesis is clearly stated and appropriate
- The contribution to practice, research, theory, or knowledge
Methodology
- Quality of the study design, experimental methods, and analytical approach
- Appropriateness of statistical methods
Results
- Clarity and adequacy of results
- Inclusion of appropriate values, whether or not statistical significance is claimed
(For all abstracts except study-design descriptions, program descriptions, or case reports)
Conclusion
- Whether the conclusions are supported by the results
- Clear statement of whether the study’s hypothesis or purpose was validated
- Absence of commercial bias
Corporate Sub-Track Abstract Submission
Presenters submitting on behalf of a corporation must select the Corporate Sub-track on the abstract submission form. Oral presentations within this sub-track are routed to non-CME oral sessions to comply with ACCME requirements, and all posters (which are non-CME) will be labeled with this sub-track.
This requirement applies to all abstracts presented by or on behalf of ACCME-defined ineligible companies. This includes:
- Full-time or part-time employees of an ineligible company
- Individuals working with a communications or marketing firm hired by a medical or pharmaceutical company
- Anyone whose presentation content was created, shaped, or influenced by an ineligible company or its agents
NOTE: This requirement does not apply to university-based PIs whose research was supported by grants. These grant relationships must be disclosed, but do not prevent acceptance into a standard CME oral session.
NOTE: Submitting to the Corporate Sub-track does not affect the likelihood of being selected for an oral presentation.
When using the Submit Abstract Form, toggle the ‘Yes – Corporate Sub-track’ option. See image here.
